Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
US Department of Justice
Mallinckrodt
Moodys
Dow
Daiichi Sankyo
Baxter
Farmers Insurance
Cipla
UBS

Generated: August 19, 2017

DrugPatentWatch Database Preview

DARVOCET A500 Drug Profile

« Back to Dashboard

What is the patent landscape for Darvocet A500, and when can generic versions of Darvocet A500 launch?

Darvocet A500 is a drug marketed by Xanodyne Pharm and is included in one NDA.

The generic ingredient in DARVOCET A500 is acetaminophen; propoxyphene napsylate. There are sixty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetaminophen; propoxyphene napsylate profile page.

Summary for Tradename: DARVOCET A500

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DARVOCET A500 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xanodyne Pharm
DARVOCET A500
acetaminophen; propoxyphene napsylate
TABLET;ORAL076429-001Sep 10, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Citi
Colorcon
Fish and Richardson
Novartis
Chubb
Daiichi Sankyo
US Army
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot